| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.3M | +85.6% | -24.1% |
| Cost of Revenue | $538K | +4.5% | -17.7% |
| R&D Expense | $13.0M | +13.8% | +118.7% |
| SG&A Expense | $4.9M | -9.6% | -13.8% |
| Operating Income | -$17.1M | +6.8% | -63.8% |
| Pre-tax Income | -$14.6M | +5.3% | -92.6% |
| Net Income | -$14.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $25.3M | -0.6% | -47.0% |
| Current Assets | $100.6M | -3.5% | -24.0% |
| Total Assets | $175.5M | -7.2% | -3.8% |
| Current Liabilities | $25.6M | -4.5% | +36.2% |
| Total Liabilities | $55.4M | -3.4% | +6.1% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$34.0M | — | — |
| Capital Expenditures | $87K | — | — |
| Investing Cash Flow | $38.0M | — | — |
| Financing Cash Flow | -$3.3M | — | — |
| Free Cash Flow | -$34.1M | — | — |
| +5.3% |
| -92.6% |
| EPS (Basic) | -$0.12 | +7.7% | -9.1% |
| EPS (Diluted) | -$0.12 | +7.7% | -9.1% |
| $120.1M |
| -8.8% |
| -7.7% |